.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Argus Health
Chinese Patent Office
Deloitte
AstraZeneca
Novartis
Medtronic
Johnson and Johnson
Healthtrust

Generated: September 24, 2017

DrugPatentWatch Database Preview

SOLU-MEDROL Drug Profile

« Back to Dashboard

Which patents cover Solu-medrol, and what generic Solu-medrol alternatives are available?

Solu-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in SOLU-MEDROL is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.

Summary for Tradename: SOLU-MEDROL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list5
Bulk Api Vendors: see list41
Clinical Trials: see list36
Patent Applications: see list2,182
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SOLU-MEDROL at DailyMed

Pharmacology for Tradename: SOLU-MEDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
SOLU-MEDROL
methylprednisolone sodium succinate
INJECTABLE;INJECTION011856-006Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
SOLU-MEDROL
methylprednisolone sodium succinate
INJECTABLE;INJECTION011856-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
SOLU-MEDROL
methylprednisolone sodium succinate
INJECTABLE;INJECTION011856-007Feb 27, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
SOLU-MEDROL
methylprednisolone sodium succinate
INJECTABLE;INJECTION011856-003Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
SOLU-MEDROL
methylprednisolone sodium succinate
INJECTABLE;INJECTION011856-005Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Express Scripts
McKesson
Colorcon
Healthtrust
Accenture
Merck
Novartis
Federal Trade Commission
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot